Cerus Announces Agreement to Supply the INTERCEPT Blood System for Platelets to French National Blood Service.
Linked as:
Extract
Cerus Announces Agreement to Supply the INTERCEPT Blood System for Platelets to French National Blood Service.
France Completes First Step to Adopt the Platelet System
CONCORD, Calif. -- Cerus Corporation (NASDAQ:CERS) announced today that it has signed an initial two-year agreement with the French nat...See the full content of this document
Sponsored links
